Use of pilot plant facilities to aid validation programs.

Area of Science:

• Biopharmaceutical manufacturing
• Process development and scale-up

Background:

• FDA guidelines permit pilot plants for process validation material generation.
• Process modifications are common during development and scale-up.
• Demonstrating product comparability between old and new processes is crucial after modifications.

Purpose of the Study:

• To apply FDA guidelines for process modifications and product comparability.
• To utilize pilot plant facilities for implementing process changes and generating validation data.
• To minimize the impact of development activities on large-scale manufacturing.

Main Methods:

• Utilized pilot plant facilities for production runs involving process modifications.
• Conducted product comparability studies between old and new manufacturing processes.
• Collected in-process samples from the new manufacturing process for validation support.

Main Results:

• Successfully implemented process modifications in the pilot plant.
• Demonstrated product comparability, meeting regulatory requirements.
• Generated necessary material for process validation studies.
• Minimized disruption to the commercial-scale manufacturing facility.

Conclusions:

• Pilot plant facilities effectively support process modifications, comparability studies, and validation.
• Strategic use of pilot plants streamlines development while safeguarding large-scale production.
• This integrated approach ensures regulatory compliance and efficient product development.